All peptides

BPC-157 vs TB-500

Updated · Educational, not medical advice

The short answer

BPC-157 is a 15-amino-acid peptide based on a stomach-protein fragment; TB-500 is a synthetic fragment of thymosin beta-4. Both are asked about for injury recovery, both rest mainly on animal research with no controlled human trials showing benefit, neither is FDA-approved, both were recommended for compounding by an FDA advisory committee in July 2026 (pending FDA action), and both are prohibited in sport.

Side by side

What it isBPC-157:BPC-157 ("body protection compound") is a pentadecapeptide, a chain of 15 amino acids, derived from a sequence in a stomach protein. It is made synthetically.TB-500:Thymosin beta-4 is a naturally occurring protein in most cells. TB-500 is a shorter, synthetic version built around its active region.
Human evidenceBPC-157:Most published work is in rodents and cell cultures, which often does not translate to people.TB-500:Evidence comes mainly from animal wound-healing and injury models. Human research on thymosin beta-4 itself is limited, and TB-500 has not been through controlled trials in people.
FDA statusBPC-157:It is not an FDA-approved drug. When prescribed, it is a compounded preparation made by a licensed pharmacy for an individual patient.TB-500:It is not an FDA-approved drug. When prescribed, it is a compounded preparation made by a licensed pharmacy for an individual patient.
Side effectsBPC-157:With injected peptides, the most commonly reported problems are injection-site redness, itching or bruising. Because human studies are small, the full side-effect profile is not known; report anything unexpected to your clinician.TB-500:With injected peptides, the most commonly reported problems are injection-site redness, itching or bruising. Because human studies are small, the full side-effect profile is not known; report anything unexpected to your clinician.
At PacificRxBPC-157:From $99/month with clinician reviewTB-500:From $159/month with clinician review

Questions

What is the difference between BPC-157 and TB-500?

BPC-157 is a 15-amino-acid peptide based on a stomach-protein fragment; TB-500 is a synthetic fragment of thymosin beta-4. Both are asked about for injury recovery, both rest mainly on animal research with no controlled human trials showing benefit, neither is FDA-approved, both were recommended for compounding by an FDA advisory committee in July 2026 (pending FDA action), and both are prohibited in sport.

Can you take BPC-157 and TB-500 together?

Some clinicians prescribe them together. The combination has not been studied in controlled human trials; your clinician decides whether either, both or neither is appropriate.

Do I need a prescription for BPC-157 or TB-500?

Yes. Both should be prescribed by a licensed clinician and prepared by a licensed pharmacy. Avoid products sold as "research use only".

Sources

More peptide comparisons